Abstract-The paraventricular nucleus (PVN) of the hypothalamus is critical to the regulation of sympathetic output. The PVN hyperactivity is known to cause increased sympathetic nerve activity in spontaneously hypertensive rats (SHRs). The purpose of this study was to determine whether glutamatergic input to the PVN contributes to heightened sympathetic outflow in hypertension. Lumbar sympathetic nerve activity, mean arterial blood pressure, and heart rate were recorded from anesthetized SHRs and Wistar-Kyoto (WKY) rats. Bilateral microinjection of an N-methyl-Daspartate receptor antagonist, 2-amino-5-phosphonopentanoic acid, or a non-N-methyl-D-aspartate receptor antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione, into the PVN dose-dependently decreased lumbar sympathetic nerve activity, mean arterial blood pressure, and heart rate in SHRs but not in WKY rats. Bilateral microinjection of kynurenic acid into the PVN also significantly decreased lumbar sympathetic nerve activity, mean arterial blood pressure, and heart rate in SHRs but not in WKY rats. Furthermore, microinjection of gabazine, a specific GABA A receptor antagonist, into the PVN increased lumbar sympathetic nerve activity, mean arterial blood pressure, and heart rate in both SHRs and WKY rats. Notably, this response was significantly attenuated in SHRs compared with that in WKY rats. In addition, kynurenic acid abolished the sympathoexcitatory and pressor responses to microinjection of gabazine into the PVN in both SHRs and WKY rats. Thus, this study provides new functional evidence that resting sympathetic vasomotor tone is maintained by tonic glutamatergic input in the PVN in SHRs. Removal of GABAergic inhibition results in augmented glutamatergic input in the PVN, which probably constitutes an important source of excitatory drive to the brain stem vasomotor neurons in hypertension. Key Words: excitatory amino acids Ⅲ hypothalamus Ⅲ sympathetic nervous system Ⅲ synaptic transmission Ⅲ autonomic nervous system Ⅲ NMDA receptors H ypertension is a significant risk factor for cardiovascular, renal, and cerebrovascular disorders. Increased sympathetic activity is often associated with hypertension and may contribute to the pathogenesis and maintenance of hypertension. 1,2 Previous studies suggested that altered central mechanisms are responsible for the elevated sympathetic outflow and arterial blood pressure in hypertension. In this regard, transection of the brain caudal to the hypothalamus reduces arterial blood pressure in spontaneously hypertensive rats (SHRs) but not in Wistar-Kyoto (WKY) rats. 3 The paraventricular nucleus (PVN) of the hypothalamus is an important region for the regulation of sympathetic output and arterial blood pressure. 4 -7 Lesions of the PVN in hypertensive rats, such as SHRs, Dahl salt-sensitive rats, and rats with renal hypertension, decrease blood pressure. 8 -11 Furthermore, inhibition of the PVN with muscimol reduces the blood pressure and sympathetic nerve activity in SHRs. 12 Thus, hyperactivity of PVN neurons may d...